Search Results - "Santisteban Eslava, M."

Body shape trajectories and risk of breast cancer: Results from the SUN study project by Sanchez Bayona, R., Sayon, C., Gardeazabal, I., Martínez-González, M.A., Santisteban Eslava, M., Toledo-Atucha, E.

Get full text

Breast cancer in Twitter: A real-world data exploratory study by Sanchez Bayona, R., Chang-Azancot, L., Alvarez de Mon, M.A., Llavero, M., Vallejo, M., Gardeazabal, I., Salas, D., Sala Elarre, P., Baraibar Argota, I., Eguren, I., Santisteban Eslava, M., Ceniceros, L., Castanon Alvarez, E.

Get full text

232P Identification of ‘secondary’ germline cancer predisposition variants from somatic tumour testing: Should we evolve towards universal screening? by Gallego Martinez, A., Imizcoz, T., Sánchez-Lorenzo, L., Mora, M., Domínguez, D., Gurpide, A., Espinos Jimenez, J., Aramendia, J.M., Chopitea Ortega, A., Santisteban Eslava, M., Ponz-Sarvise, M., González, J.L., Landa Magdalena, A., Sanmamed, M.F., Alkorta-Aranburu, G., Rodriguez Rodriguez, J., Herráiz Bayod, T., Gonzalez Martin, A., Patiño-García, A.

Get full text

406P Phase Ib safety and efficacy of nadunolimab/gemcitabine/carboplatin in mTNBC by Lopez-Tarruella Cobo, S., Stradella, A., Ortega, P. Tolosa, Antolín-Novoa, S., Eslava, M. Santisteban, Garcia-Corbacho, J., Guerrero Zotano, A.L., Borrego, M. Ruiz, Caffarel, M. Muñoz, Losic, N., Gyllenbäck, E. Jaensson, Skoog, P., Johansen Blanco, H., Soto-Castillo, J.J., Alva Bianchi, M., Rendo, C. Reboredo, Casas, M., Caparroso, N., Montes, S. Bezares, Ribas, I. Garcia

Get full text

1590PBody shape trajectories and risk of breast cancer: Results from the SUN study project by Sanchez Bayona, R, Sayon, C, Gardeazabal, I, Martínez-González, M A, Santisteban Eslava, M, Toledo-Atucha, E

Get full text

1029P Addition of dendritic cell vaccines to neoadjuvant chemotherapy in HER2 negative breast cancer patients by Urrizola, A., Solans, B., Bayona, R. Sanchez, Mejías, L., Vilalta, A., Cruz, S. de la, Olartecoechea, B., Rodríguez-Spiteri, N., Hato, L., Díaz de Cerio, A. Lopez, Inoges, S., Eslava, M. Santisteban

Get full text

Abstract P6-17-31: Real world evidence of neoadjuvant treatment based on dual blockade with pertuzumab plus trastuzumab for early HER2+ breast cancer: The NeoPETRA study by Chacón, JI, Saura, C, Ciruelos, E, Alonso, JI, de la Morena, P, Santisteban Eslava, M, Gallegos, I, de Luna, A, Dalmau, E, González-Santiago, S

“…Background: Evidence from clinical trials supports the neoadjuvant use of pertuzumab and trastuzumab with chemotherapy to improve the pathologic complete…”
Get full text

360P_PRBreast cancer in Twitter: A real-world data exploratory study by Sanchez Bayona, R, Chang-Azancot, L, Alvarez de Mon, M A, Llavero, M, Vallejo, M, Gardeazabal, I, Salas, D, Sala Elarre, P, Baraibar Argota, I, Eguren, I, Santisteban Eslava, M, Ceniceros, L, Castanon Alvarez, E

Get full text

199P Adoptive PD1+ tumor-infiltrating lymphocyte therapy for metastatic TNBC: First results of the safety run-in phase of the TILS001 clinical trial by Angelats, L., Eslava, M. Santisteban, Manich, C. Saura, Ciruelos, E.M., González-Navarro, E.A., Alvarez-Vallina, L., Lasarte, J.J., Gros, A., Vizcay, Á.M., Oliveira, M., Ortega, P. Tolosa, Rego, M. Español, Brasó-Maristany, F., Galván, P., Chic, N., Villanueva, L., Ruiz, J. Canes, Juan, M., Pascual, T., Prat, A.

Get full text